The Flow Cytometry In Oncology And Immunology Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The Flow Cytometry In Oncology And Immunology Global Market Report 2024 demonstrates a significant increase in market size. It is predicted to grow from $2.11 billion in 2024 to $2.33 billion in 2025, showing a compound annual growth rate (CAGR) of 10.4%.
The global market for flow cytometry in oncology and immunology is projected to reach $3.46 billion in 2029, expanding at a compound annual growth rate of 10.4%.
Download Your Free Sample of the 2025 Flow Cytometry In Oncology And Immunology Market Report and Uncover Key Trends Now!The key drivers in the flow cytometry in oncology and immunology market are:
• Increasing integration of flow cytometry with genomics and proteomics
• Growing adoption of single-cell analysis in the field
• Expanding applications of this technique in diagnosing infectious diseases
• Rising incidence of cancer globally and the use of point-of-care flow cytometry for diagnosis
The flow cytometry in oncology and immunology market covered in this report is segmented –
1) By Type: Immunology, Oncology
2) By Technology: Cell-Based Flow Cytometry, Bead-Based Flow Cytometry
3) By Application: Translational Research, Clinical Research
4) By End User: Hospitals, Diagnostic Laboratories, Reference Laboratories, Pharmaceutical And Biotechnology Companies, Academic Research Institutes, Contract Research Organizations, Other End Users
The key trends in the flow cytometry in oncology and immunology market are:
• Integration with genomics and proteomics is an emerging trend.
• There is a growing adoption of single-cell analysis.
• An increased application in infectious diseases is becoming apparent.
• The trend of immunophenotyping for immunotherapy is on the rise.
The major players in the flow cytometry in oncology and immunology market are:
• Thermo Fisher Scientific Inc
North America was the largest region in the flow cytometry in oncology and immunology market in 2024